ESC 365 - Antithrombotic treatment after TAVI in patients with CAD: what matters most valve or atherosclerosis .

Open Access

Antithrombotic treatment after TAVI in patients with CAD: what matters most valve or atherosclerosis .

Session: Antithrombotic therapy after TAVI

Topic: Interventional Cardiology

Event: ESC Congress 2021 - The Digital Experience

Congress Session

3 more presentations in this session

Antithrombotic treatment and valve-related outcomes (GALILEO 4D, ATLANTIS 4D): do they matter .

Antithrombotic treatment after TAVI in patients without indication for anticoagulation: anything else than aspirin.

Antithrombotic treatment after TAVI in patients with indication for anticoagulation.

Access the full session

Antithrombotic therapy after TAVI

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

Related content

Open Access

Pharmacological treatment: how to choose your drug (if any)

19 March 2022

Open Access

Acute decompensated heart failure and acute pulmonary edema.

19 March 2022

Open Access

Demystifying artificial intelligence.

23 October 2021

This platform is supported by